JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gleason, M. M.
Right arrow Articles by Hieble, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gleason, M. M.
Right arrow Articles by Hieble, J. P.

Ability of SK&F 104078 and SK&F 104856 to identify alpha-2 adrenoceptor subtypes in NCB20 cells and guinea pig lung

MM Gleason and JP Hieble

Department of Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania.

Alpha-2 adrenoceptors were characterized in three tissue culture cell lines and in membrane homogenates of guinea pig lung via the ability of a series of alpha adrenoceptor antagonists to inhibit the binding of [3H]clonidine, [3H]UK-14,304 and [3H]rauwolscine. The cells studied included those known to possess receptors of alpha-2A (HT29) and alpha- 2B (NG108-15) subtypes as well as the previously uncharacterized NCB20 cells. Correlation of the ability of the antagonists to inhibit [3H]clonidine or [3H]UK-14,304 binding did not identify alpha-2 adrenoceptor subtypes. On the other hand, correlation of antagonist affinities against [3H]rauwolscine binding showed HT29 cells and guinea pig lung to have similar characteristics (r = 0.911) as did NG108-15 and NCB20 cells (r = 0.985). These data suggest subtle differences in the binding of [3H]agonists and [3H]antagonists to the alpha-2 adrenoceptor, resulting in the failure of [3H]clonidine and [3H]UK- 14,304 to recognize differences between alpha-2A and alpha-2B receptor subtypes. 6-chloro-9-[(3-methyl-2-butenyl)oxy]-3-methyl-1H-2,3,4,5- tetrahydro-3- benzazepine (SK&F 104078) did not differentiate between the alpha-2A and alpha-2B receptor subtypes. However, 2-vinyl-7-chloro- 3,4,5,6-tetrahydro-4-methylthieno[(4,3,2ef] [3]benzazepine (SK&F 104856), which has similar selectivity in functional in vitro models, was about 35-fold more potent in displacing [3H]rauwolscine binding to the alpha-2B site. These data provide additional evidence that the functional subclassification of alpha-2 adrenoceptors based on sensitivity to SK&F 104078 and SK&F 104856 subdivides this receptor in a different manner than does the alpha-2A/alpha-2B subclassification scheme.

Volume 259, Issue 3, pp. 1124-1132, 12/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J.-S. Wang and L.-J. Cheng
Effect of Strenuous, Acute Exercise on {alpha}2-Adrenergic Agonist–Potentiated Platelet Activation
Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1559 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Pineda, J. A. Ruiz-Ortega, and L. Ugedo
Receptor Reserve and Turnover of Alpha-2 Adrenoceptors that Mediate the Clonidine-Induced Inhibition of Rat Locus Coeruleus Neurons In Vivo
J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 690 - 698.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics.